PharmaBlock Sciences Nanjing Inc Class A (300725)

Shenzhen

Currency in CNY

41.78

+0.25(+0.60%)

Delayed Data·22:20:54

Fair Value

Unlock Value

Day's Range

41.25

42.03

52 wk Range

27.07

53.54

300725 Income Statement

Featured here, the Income Statement (earnings report) for PharmaBlock Sciences Nanjing Inc Class A, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2023

01/01

2023

31/12

2024

31/12

Total Revenues

aa.aa

1,022.23

1,201.63

1,594.7

1,725.2

1,688.62

Total Revenues Growth

aa.aa

+54.36%

+17.55%

+32.71%

+8.18%

-2.12%

Cost Of Revenues

aa.aa

556.44

632.85

878.71

1,018.01

1,105.88

Gross Profit

aa.aa

465.79

568.78

715.99

707.2

582.74

Gross Profit Growth

aa.aa

+37.99%

+22.11%

+25.88%

-1.23%

-17.6%

Gross Profit Margin %

aa.aa

45.57%

47.33%

44.9%

40.99%

34.51%

Other Operating Expenses, Total

aa.aa

253.98

299.34

435.78

447.24

356.1

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+44.43%	+17.86%	+45.58%	+2.63%	-20.38%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	90.93	114.02	168.32	169.17	107.33
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	156.68	177.04	255.57	263.27	242.37
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6.37	8.28	11.89	14.8	6.4

Operating Income

aa.aa

211.81

269.44

280.21

259.95

226.64

Operating Income Growth

aa.aa

+30.98%

+27.21%

+4%

-7.23%

-12.81%

EBIT Margin %

aa.aa

20.72%

22.42%

17.57%

15.07%

13.42%

Net Interest Expenses

aa.aa

6.04

240.24

-19.02

-41.3

-15.15

Net Interest Expenses Growth

aa.aa

+7,418.89%

+3,879.15%

-107.92%

-117.1%

+63.33%

Interest Expense, Total

aa.aa

-0.63

-9.18

-45.72

-66.1

-60.91

Interest And Investment Income

aa.aa

6.67

249.42

26.7

24.79

45.76

Other Non Operating Expenses, Total

aa.aa

-23.72

-3.44

33.53

5.04

20.69

EBT, Excl. Unusual Items

aa.aa

194.13

506.23

294.72

223.69

232.19

Gain (Loss) On Sale Of Assets

aa.aa

0.04

0.42

Other Unusual Items, Total

aa.aa

10.38

-0.17

26.56

18.6

7.79

EBT, Incl. Unusual Items

aa.aa

204.5

507.77

323.26

221.38

248.9

EBT, Incl. Unusual Items Growth

aa.aa

+18.66%

+148.29%

-36.34%

-31.52%

+12.43%

EBT, Incl. Unusual Items Margin

aa.aa

20.01%

42.26%

20.27%

12.83%

14.74%

Income Tax Expense

aa.aa

20.3

-2.63

24.01

29.36

Net Income to Company

aa.aa

184.2

503.77

325.89

197.36

219.54

Minority Interest

aa.aa

-17.21

-11.67

Net Income

aa.aa

184.21

486.56

314.22

197.36

219.54

Net Income Growth

aa.aa

+21.13%

+164.14%

-35.42%

-37.19%

+11.24%

Net Income Margin %

aa.aa

18.02%

40.49%

19.7%

11.44%

13%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

184.21

486.56

314.22

197.36

219.54

Basic EPS - Continuing Operations

aa.aa

0.99

2.46

1.58

0.99

1.1

Basic EPS - Continuing Operations Growth

aa.aa

+21.41%

+148.48%

-35.77%

-37.34%

+11.11%

Diluted EPS - Continuing Operations

aa.aa

0.98

2.44

1.57

0.98

1.1

Diluted EPS - Continuing Operations Growth

aa.aa

+20.19%

+148.98%

-35.66%

-37.58%

+12.24%

Basic Weighted Average Shares Outstanding

aa.aa

186.07

197.79

198.88

199.35

199.58

Diluted Weighted Average Shares Outstanding

aa.aa

187.97

199.41

200.14

201.39

199.58

Dividend Per Share

aa.aa

0.08

0.1

0.31

0.28

Dividend Per Share Growth

aa.aa

-33.36%

+30.04%

+210%

-9.68%

EBITDA

aa.aa

236.28

322.64

366.45

374.25

355.41

EBITDA Growth

aa.aa

+29.24%

+36.55%

+13.58%

+2.13%

-5.03%

EBITDA Margin %

aa.aa

23.11%

26.85%

22.98%

21.69%

21.05%

EBIT

aa.aa

211.81

269.44

280.21

259.95

226.64

* In Millions of CNY (except for per share items)

FAQ

What was PharmaBlock Sciences A’s revenue at year end?

At the end of the last reported fiscal year, PharmaBlock Sciences A (300725) recorded total revenue of 1,688.62.

How much revenue did PharmaBlock Sciences A report in the most recent quarter?

In its most recent quarterly earnings report, PharmaBlock Sciences A posted revenue of 499.33.

What was PharmaBlock Sciences A’s net income for the year?

For the full year, PharmaBlock Sciences A reported net income of 219.54.

How much net income did PharmaBlock Sciences A post in the last quarter?

In the most recent quarter, PharmaBlock Sciences A (300725) posted net income of 40.89.

What was PharmaBlock Sciences A’s gross profit for the year?

Gross profit for the year was reported at 582.74.

How much gross profit did PharmaBlock Sciences A generate last quarter?

PharmaBlock Sciences A recorded gross profit of 188.81 in its latest quarterly report.

What was PharmaBlock Sciences A’s annual operating income?

For the full year, PharmaBlock Sciences A (300725) reported operating income of 226.64.

What was PharmaBlock Sciences A’s operating income last quarter?

Quarterly operating income was 94.59.

What was PharmaBlock Sciences A’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 126.78.

What was the quarter-over-quarter change in EBITDA for PharmaBlock Sciences A?

EBITDA changed by 115.51% compared to the last quarter.

What is PharmaBlock Sciences A’s most recent gross profit margin?

The latest reported gross profit margin for PharmaBlock Sciences A (300725) is 37.81%.

What is PharmaBlock Sciences A’s most recent net income margin?

Net income margin based on recent financials is 8.19%.

What is PharmaBlock Sciences A’s most recent EBIT margin?

PharmaBlock Sciences A reported an EBIT margin of 18.94% based on current figures.

How did PharmaBlock Sciences A’s revenue change compared to the previous quarter?

Revenue changed by 7.45% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for PharmaBlock Sciences A?

In the latest quarter 2026, gross profit changed by 68.08% from the previous quarter.

S&P/TSX

33,023.32

+552.34

+1.70%

S&P/TSX 60

1,911.63

+28.97

+1.54%

US 30

50,138.00

+2.1

0.00%

US 500

6,957.40

-7.4

-0.11%

S&P 500 VIX

17.36

-0.40

-2.25%

DAX

25,014.87

+293.41

+1.19%

Dollar Index

96.68

-0.008

-0.01%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	68.62	-0.17%	25.66M
Barrick Mining	63.27	+2.46%	13.28M
Suncor Energy	74.12	+0.90%	11.18M
Toronto Dominion Bank	133.17	+0.89%	8.22M
Bank of Nova Scotia	105.29	+0.95%	6.73M
RBC	236.29	+1.53%	4.68M
Bank of Montreal	196.29	+1.45%	4.18M

Name	Last	Chg. %	Vol.
Grounded People Apparel	0.100	+1,900.00%	2.50K
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Hempsana Holdings	0.01	+100.00%	1.00K
BGX Black Gold Exploration	0.01	+100.00%	1.07M

Name	Last	Chg. %	Vol.
Metamaterial	0.25	-92.86%	0.00
Planet Based Foods Global	0.01	-81.82%	35.00K
TripSitter Clinic	0.15	-69.39%	1.50K
Champion Electric	0.005	-50.00%	216.91K
Ampd Ventures	0.01	-50.00%	3.50K
Molecule Holdings	0.005	-50.00%	20.11K
Vice Health Wellness	0.005	-50.00%	2.22M

Trending Stocks

Name	Last	Chg. %	Vol.
Air Canada	20.21	-4.49%	2.98M
Constellation Software	2,470.03	+1.48%	78.41K
Canadian Imperial Bank	132.94	+0.64%	1.90M
Toronto Dominion Bank	133.17	+0.89%	8.22M
Hut 8	77.110	+6.46%	1.06M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaa A	87.44	+63.78%	143.21
Aaaaaaa	34.37	+52.58%	52.44
Aaaaaaaaaaaa A Aaa	21.19	+52.40%	32.29
Aaaaaaaaaaaaaaaaaaaa	59.81	+49.81%	89.60
Aaaaa Aaaaaaaaaaaa A	8.14	+43.04%	11.64
Aaaaaa Aaaaaa	2,470.03	+41.48%	3,494.60
Aaaaaaaaaa Aaaaa	109.92	+41.31%	155.33

Name	Last	Upside	Fair Value
Aaaaaaaaaa A	87.44	+63.78%	143.21
Aaaaaaa	34.37	+52.58%	52.44
Aaaaaaaaaaaa A Aaa	21.19	+52.40%	32.29
Aaaaaaaaaaaaaaaaaaaa	59.81	+49.81%	89.60
Aaaaa Aaaaaaaaaaaa A	8.14	+43.04%	11.64
Aaaaaa Aaaaaa	2,470.03	+41.48%	3,494.60
Aaaaaaaaaa Aaaaa	109.92	+41.31%	155.33

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

PharmaBlock Sciences Nanjing Inc Class A (300725)

300725 Income Statement

FAQ

What was PharmaBlock Sciences A’s revenue at year end?

How much revenue did PharmaBlock Sciences A report in the most recent quarter?

What was PharmaBlock Sciences A’s net income for the year?

How much net income did PharmaBlock Sciences A post in the last quarter?

What was PharmaBlock Sciences A’s gross profit for the year?

How much gross profit did PharmaBlock Sciences A generate last quarter?

What was PharmaBlock Sciences A’s annual operating income?

What was PharmaBlock Sciences A’s operating income last quarter?

What was PharmaBlock Sciences A’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for PharmaBlock Sciences A?

What is PharmaBlock Sciences A’s most recent gross profit margin?

What is PharmaBlock Sciences A’s most recent net income margin?

What is PharmaBlock Sciences A’s most recent EBIT margin?

How did PharmaBlock Sciences A’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for PharmaBlock Sciences A?

Trending Stocks